Just a moment...

Top
Help
AI Drafter

Generate professional replies to Show Cause Notices, assessment orders, audit objections, and other legal communications using TaxTMI's AI Drafter.

Step 1 – Issue Identification & Review

The AI analyses your query, notice, order, or uploaded documents and identifies the key issues involved.

• Review the issues identified by the AI
• Add, edit, remove, or refine issues as required


Step 2 – Draft Generation

Once you approve the issues, the AI performs issue-wise legal research and prepares a structured draft response.

• Relevant statutory provisions
• Judicial precedents and Supreme Court, High Court and other citations
• Issue-wise legal analysis
• Practical arguments and supporting content
• Professionally structured draft ready for further review.

Try Now
×

By creating an account you can:

Logo TaxTMI
>
Call Us / Help / Feedback

Contact Us At :

E-mail: [email protected]

Call / WhatsApp at: +91 99117 96707

For more information, Check Contact Us

FAQs :

To know Frequently Asked Questions, Check FAQs

Most Asked Video Tutorials :

For more tutorials, Check Video Tutorials

Submit Feedback/Suggestion :

Email :
Please provide your email address so we can follow up on your feedback.
Category :
Description :
Min 15 characters0/2000
TMI Blog
Home / RSS

CCI approves acquisition of Corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings Limited

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....CI approves acquisition of Corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings Limited <br>News and Press Release<br>Dated:- 14-6-2022<br><BR>The Competition Commission of India (CCI) approves acquisition of Corporate restructuring of GlaxoSmithKline Consumer Healthcare Holdings (No.2) Limited ("JVCO") under Section 31(1) of the Competition Act, 2002. The Proposed Combination ....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger and the share exchange steps involving the shareholders of JVCO. Immediately following completion of the demerger and share exchange steps, the shareholding of Haleon will be held by a combination of GSK, GSK's affiliates and GSK's shareholders (together representing 68% of Haleon&#39;s voting rights) an....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....d (directly/indirectly) Pfizer (representing 32% of Haleon&#39;s voting rights). GSK, registered in the UK, is a pharmaceuticals company active worldwide in the research, development, manufacturing, and marketing of prescription pharmaceuticals, vaccines and consumer healthcare products. In the consumer healthcare segment, it is active in the research, development, manufacturing, and marketing of....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

.... products which are typically available without prescription (i.e., OTC), for various indications. Pfizer is a research-based biopharmaceutical company and is engaged globally in the research, development, manufacturing, and marketing of innovative medicines. Haleon is a new incorporated entity that presently does not have any business activities. JVCO was established in 2019, combining the re....

X X   X X   Extracts   X X   X X

Full Text of the Document

X X   X X   Extracts   X X   X X

....spective legacy consumer healthcare business worldwide, including India, of GSK and Pfizer. JVCO (through its subsidiaries and affiliates) is engaged in the manufacture and distribution of consumer healthcare products. Detailed order of the CCI will follow.<BR> News - Press release - PIB....